| Item Type | Name |
|
Concept
|
Calcium Channels, T-Type
|
|
Concept
|
Calcium
|
|
Concept
|
Calcium Channel Blockers
|
|
Concept
|
Calcium Channels, L-Type
|
|
Academic Article
|
Long-term effects of antihypertensive regimens on renal hemodynamics and proteinuria.
|
|
Academic Article
|
Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
|
|
Academic Article
|
Effects of an ACE inhibitor combined with a calcium channel blocker on progression of diabetic nephropathy.
|
|
Academic Article
|
Angiotensin converting enzyme inhibitors and calcium antagonists alone or combined: does the progression of diabetic renal disease differ?
|
|
Academic Article
|
Calcium antagonism abolishes the antipressor action of vasopressin (V1) receptor antagonism.
|
|
Academic Article
|
Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
|
|
Academic Article
|
Current issues in treating the hypertensive patient with diabetes: focus on diabetic nephropathy.
|
|
Academic Article
|
Effect of calcium channel or beta-blockade on the progression of diabetic nephropathy in African Americans.
|
|
Academic Article
|
Renal mortality associated with non-insulin-dependent diabetes mellitus.
|
|
Academic Article
|
Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients.
|
|
Academic Article
|
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy.
|
|
Academic Article
|
Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy.
|
|
Academic Article
|
Antihypertensive therapy and the risk of type 2 diabetes mellitus.
|
|
Academic Article
|
Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
|
|
Academic Article
|
Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.
|
|
Academic Article
|
Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
|
|
Academic Article
|
Diabetic hypertensive patients: improving their prognosis.
|
|
Academic Article
|
A practical approach to achieving recommended blood pressure goals in diabetic patients.
|
|
Academic Article
|
Class differences in the effects of calcium channel blockers in the rat remnant kidney model.
|
|
Academic Article
|
A perspective on converting enzyme inhibitors and calcium channel antagonists in diabetic renal disease.
|
|
Academic Article
|
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.
|
|
Academic Article
|
Therapeutic approaches to achieve desired blood pressure goals: focus on calcium channel blockers.
|
|
Academic Article
|
Optimal treatment of hypertension in African Americans. Reaching and maintaining target blood pressure goals.
|
|
Academic Article
|
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
|
|
Academic Article
|
Design and statistical aspects of the African American Study of Kidney Disease and Hypertension (AASK).
|
|
Academic Article
|
Evaluation and treatment of patients with systemic hypertension.
|
|
Academic Article
|
Quality of life measured in a practice-based hypertension trial of an angiotensin receptor blocker.
|
|
Academic Article
|
Diabetes and chronic kidney disease: tragedy and challenge.
|
|
Academic Article
|
Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study.
|
|
Academic Article
|
Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model.
|
|
Academic Article
|
Differential effects of calcium antagonist subclasses on markers of nephropathy progression.
|
|
Academic Article
|
The role of calcium antagonists in chronic kidney disease.
|
|
Academic Article
|
Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans.
|
|
Academic Article
|
The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension.
|
|
Academic Article
|
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
|
|
Academic Article
|
Calcium antagonists: effects on cardio-renal risk in hypertensive patients.
|
|
Academic Article
|
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]).
|
|
Academic Article
|
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
|
|
Academic Article
|
Is ethnicity a factor in choice of antihypertensive drug?
|
|
Academic Article
|
The cardiometabolic syndrome and calcium channel blocker combination drugs.
|
|
Academic Article
|
Clinical importance of microalbuminuria in diabetes and hypertension.
|
|
Academic Article
|
Antihypertensive therapy in the presence of proteinuria.
|
|
Academic Article
|
Combined therapy with a calcium channel blocker and an angiotensin II type 1 receptor blocker.
|
|
Academic Article
|
Blood pressure control in the patient with difficult-to-control hypertension: which agent for which patient?
|
|
Academic Article
|
Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control.
|
|
Academic Article
|
Who should be treated with combination therapy as initial treatment for hypertension?
|
|
Academic Article
|
Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial.
|
|
Academic Article
|
Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease.
|
|
Academic Article
|
Effects of different calcium antagonists on proteinuria associated with diabetes mellitus.
|
|
Academic Article
|
Combination therapy with Renin-Angiotensin-aldosterone receptor blockers for hypertension: how far have we come?
|
|
Academic Article
|
The effects of calcium antagonists on renal hemodynamics, urinary protein excretion, and glomerular morphology in diabetic states.
|
|
Academic Article
|
Lowering blood pressure with beta-blockers in combination with other renin-angiotensin system blockers in patients with hypertension and type 2 diabetes: results from the GEMINI Trial.
|
|
Academic Article
|
Calcium antagonists: Do they equally protect against kidney injury?
|
|
Academic Article
|
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
|
|
Academic Article
|
Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
|
|
Academic Article
|
Efficacy and safety of darusentan in patients with resistant hypertension: results from a randomized, double-blind, placebo-controlled dose-ranging study.
|
|
Academic Article
|
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
|
|
Academic Article
|
Should proteinuria reduction be the criterion for antihypertensive drug selection for patients with kidney disease?
|
|
Academic Article
|
Resistant hypertension: an overview of evaluation and treatment.
|
|
Academic Article
|
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
|
|
Academic Article
|
A role for calcium in radiocontrast-induced reductions in renal hemodynamics.
|
|
Academic Article
|
The place for calcium channel blockers in the treatment of hypertension in patients with diabetes mellitus.
|
|
Academic Article
|
Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
|
|
Academic Article
|
Initial combination antihypertensives: let's ACCELERATE.
|
|
Academic Article
|
The evolution of antihypertensive therapy: an overview of four decades of experience.
|
|
Academic Article
|
Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers.
|
|
Academic Article
|
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
|
|
Academic Article
|
Renal effects of antihypertensive medications: an overview.
|
|
Academic Article
|
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
|
|
Academic Article
|
Risk of hyperkalemia in nondiabetic patients with chronic kidney disease receiving antihypertensive therapy.
|
|
Academic Article
|
Combination therapy in hypertension.
|
|
Academic Article
|
Fixed-dose combination and chronic kidney disease progression: which is the best?
|
|
Academic Article
|
Effects of ACE inhibitors and calcium antagonists alone or combined on progression of diabetic nephropathy.
|
|
Academic Article
|
Newer renin-angiotensin-aldosterone system blocker combinations: is there an advantage?
|
|
Academic Article
|
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
|
|
Academic Article
|
Treatment of renal failure and blood pressure.
|
|
Academic Article
|
Preservation of renal function: the spectrum of effects by calcium-channel blockers.
|
|
Academic Article
|
A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.
|
|
Academic Article
|
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
|
|
Academic Article
|
Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study.
|
|
Academic Article
|
The author replies.
|
|
Academic Article
|
The OSCAR for cardiovascular disease prevention in chronic kidney disease goes to blood pressure control.
|
|
Academic Article
|
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
|
|
Academic Article
|
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.
|
|
Academic Article
|
Effects of combining azilsartan medoxomil with amlodipine in patients with stage 2 hypertension.
|
|
Academic Article
|
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
|
|
Academic Article
|
Effect of antihypertensive treatment on 24-h blood pressure variability: pooled individual data analysis of ambulatory blood pressure monitoring studies based on olmesartan mono or combination treatment.
|
|
Academic Article
|
Hypertension.
|
|
Academic Article
|
Cardiovascular Benefits of Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade in Patients Achieving Tight Blood Pressure Control and With Resistant Hypertension.
|